Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody drugs
Pharma
InflaRx may find path forward for COVID drug in skin disorder
Positive post hoc analyses could prompt InflaRx to revive development of its COVID med vilobelimab in the rare skin disorder pyoderma gangrenosum.
Fraiser Kansteiner
Jan 2, 2026 10:25am
Amgen nabs FDA nod for Uplizna in generalized myasthenia gravis
Dec 12, 2025 9:49am
GSK's Tesaro, AnaptysBio lock horns over Jemperli agreement
Nov 21, 2025 9:46am
Regeneron, AZ regulatory plans bolstered by phase 3 wins
Nov 7, 2025 2:00pm
Roche pads case for Gazyva in immune-mediated kidney conditions
Oct 28, 2025 9:55am
Fujifilm Biotechnologies christens $3.2B antibody plant in NC
Sep 24, 2025 1:00pm
